SEC Form 4
Valion Bio, Inc. (VBIO) insider trading
No open-market VBIO insider purchases or sales were filed in the 12 months to Oct 26, 2026.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $0
- 0 filings
Who traded VBIO, and when
VBIO daily close from Apr 28, 2026 to Oct 26, 2026, between $0.82 and $27.75, last $0.82. No open-market insider purchases or sales were filed in this period.
No open-market insider purchases or sales were filed in the last 12 months.
Open-market trades
0 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| No open-market purchases or sales in the last 12 months. | ||||||
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
| No open-market purchases or sales in the last 12 months. | |||||||
GET /stocks/filings/vX/form-4?tickers=VBIO&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"VBIO"
],
"issuer_cik": "0001787740",
"owner_cik": "0001861556",
"accession_number": "0001683168-26-007396",
"form_type": "4",
"filing_date": "2026-09-24",
"period_of_report": "2026-09-18",
"issuer_name": "Valion Bio, Inc.",
"issuer_trading_symbol": "VBIO",
"owner_name": "Wolf Lisa G",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "COO & CFO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-18",
"transaction_code": "F",
"equity_swap_involved": false,
"transaction_shares": 2,
"transaction_price_per_share": 2.12,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 27,
"transaction_value": 4.24,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F2",
"description": "The Reporting Person forfeited 2 shares of Common Stock upon vesting and settlement of 4 outstanding Restricted Stock Units to cover tax withholdings, using the market price of the Issuer's Common Stock at the time of forfeiture."
},
{
"id": "F4",
"description": "These numbers have been adjusted to reflect the reverse stock split of the Common Stock of Valion Bio, Inc., which underwent a reverse stock split at a ratio of 1-for-25 on August 31, 2026."
}
]
},
{
"tickers": [
"VBIO"
],
"issuer_cik": "0001787740",
"owner_cik": "0001861556",
"accession_number": "0001683168-26-007396",
"form_type": "4",
"filing_date": "2026-09-24",
"period_of_report": "2026-09-18",
"issuer_name": "Valion Bio, Inc.",
"issuer_trading_symbol": "VBIO",
"owner_name": "Wolf Lisa G",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "COO & CFO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-18",
"transaction_code": "M",
"equity_swap_involved": false,
"transaction_shares": 4,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 29,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "Each Restricted Stock Unit is convertible into one share of Common Stock."
},
{
"id": "F3",
"description": "Fifty percent (50%) of the Restricted Stock Units vested upon the one (1) year anniversary of the date of grant, December 18, 2024 (the \"Vesting Commencement Date\"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 4 records
- Option exercises3 records
- Tax withholding1 record
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Valion Bio, Inc.'s CEO sold stock?
No. Dean Zikria and Michael K. Handley (CEOs) made no open-market sales filed as CEO in the last 12 months.
How current is VBIO’s insider data?
These are VBIO Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track VBIO insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for VBIO every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.